| ★ | Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients | ATS 2026 | | 68 | Estados Unidos | |
| 10 | Why Fewer Than Half of Referred Patients Reach Kidney Transplant Evaluation | | 217 | Estados Unidos | 69 |
| 15 | Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy | | 199 | Estados Unidos | 68 |
| 3 | Tezepelumab Reduced Severe Asthma Exacerbations Across Phenotypes | ATS 2026 | | 122 | Estados Unidos | 72 |
| 2 | How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD | | 109 | Estados Unidos | 72 |
| 7 | Obinutuzumab Achieves 95.5% Remission in INS, May Shift Steroid-Sparing Treatment Strategies | | 109 | Estados Unidos | 69 |
| 13 | Ruxolitinib, Tapinarof, Roflumilast: What's New for Pediatric AD | | 102 | Estados Unidos | 69 |
| 20 | VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes | | 96 | Estados Unidos | 68 |
| 1 | MAESTRO-NASH: Resmetirom May Reduce Cardiovascular Risk in MASH, With or Without Statins | | 86 | Estados Unidos | 75 |
| 5 | Juana Hutchinson-Colas, MD, OB/GYN | RWJBarnabas Health @rwjbarnabashealth | 86 | Estados Unidos | 72 |
| 6 | Diagnosing Asthma in Kids Under 5 | GINA 2025 Criteria & ICS Decisions | | 84 | Estados Unidos | 71 |
| 4 | SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma | | 78 | Estados Unidos | 72 |
| 8 | Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy | | 55 | Estados Unidos | 69 |
| 17 | SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026 | | 48 | Estados Unidos | 68 |
| 14 | Primary Aldosteronism More Common Than Previously Believed, Requires Increased Screening | | 47 | Estados Unidos | 68 |
| 18 | Importance of Cervical Cancer Screenings and Prevention | UT Tyler Health Science Center @uthealthnortheast | 38 | Estados Unidos | 68 |
| 19 | HPA-Axis Assessment Allows for Improved Corticosteroid Response Analysis | | 32 | Estados Unidos | 68 |
| 9 | Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026 | | 31 | Estados Unidos | 69 |
| 16 | How Should Clinicians Address the Link Between Atopic Dermatitis and Allergy? With Jay Lieberman, MD | | 13 | Estados Unidos | 68 |
| 12 | Diabetes Increases Mortality Risk Across All Major Organ Transplants | | 12 | Estados Unidos | 69 |
| 11 | Patch Testing, Nickel, & IL-13 Inhibitors: Rethinking Eczematous Dermatitis Diagnosis | | 11 | Estados Unidos | 69 |